Search
for
Sort by
Research 421–450 of 1000+
- Oral Retinoids in Dermatology
- Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
- Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
- An Analysis of Follicular Punches, Mechanics, and Dynamics in Follicular Unit Extraction
- Mitoxantrone
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- More than One Gene Involved in Monilethrix: Intracellular but also Extracellular Players
- Demodicosis in ferrets (Mustela putorius furo)
- Is hormonal treatment still an option in acne today?
- Management of CAH during pregnancy
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Teledermatology consultation using a smartphone multimedia messaging service for common skin diseases in the Korean army: a clinical evaluation of its diagnostic accuracy
- Lack of response of alopecia areata to pimecrolimus cream
- Medikamentöse Therapie des benignen Prostatasyndroms
- Tinea capitis favosa in Poland
- Non-invasive analysis of penetration and storage of Isoconazole nitrate in the stratum corneum and the hair follicles
- Treatment of multiple scalp basal cell carcinomas by photodynamic therapy
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Hair growth promotion effect of cedrol cream and its dermatopharmacokinetics
- Multiple apocrine hidrocystomas successfully treated with botulinum toxin A
- Pinnal Diseases
- Wound-Induced Hair Neogenesis Model
- Hair-Bearing Flaps for Baldness
- Anti-androgen therapy in dermatology: a review
- Update on the treatment of androgenetic alopecia.
- Monilethrix
- Effect of Age on Local Action of Adrenocortical Hormones.
- Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial
- Factors associated with quality of life in patients with central centrifugal cicatricial alopecia: A cross-sectional study
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)